Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

  • Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/10/18 (What's New)

Summary

  • Management of cardiovascular disease in patients with HIV is based on research conducted in the general population
  • Recommended approach involves risk-factor reduction, use of antiplatelet therapy, beta-blockers, angiotensin inhibitors or angiotensin receptor blockers, statins or antilipidic agents, and other interventions where necessary (Table 12)[Smith 2006; ACC/AHA 2013]
  • Referral to a cardiologist is recommended in patients with established coronary artery disease or when baseline evaluation is suggestive of disease

Action required